Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0200
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 54.69 million as of August 21, 2026. Its market cap has decreased by -80.77% in one year.
Market Cap
54.69M
Enterprise Value
24.15M
Revenue
21.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 54.69M, an increase of 345.89%. That is a compound annual growth rate of 15.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 54.69M | -79.42% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 90.89M |
| Prescient Therapeutics | 80.97M |
| Arovella Therapeutics | 76.15M |
| Immutep | 75.16M |
| Amplia Therapeutics | 74.43M |
| Avecho Biotechnology | 73.41M |
| Entropy Neurodynamics | 61.19M |
| Radiopharm Theranostics | 52.05M |